Search Results for Factor XI

Product: Ceveron® s100

Product: Chromogenix S-2222™

Product: Chromogenix S-2366™

Product: DiaPharma Human vWF (FVIII free) Purified Cofactor

Product: DiaPharma α-Thrombin Purified Enzyme, Human (100µg)

Product: DiaPharma α-Thrombin Purified Enzyme, Human (1mg)

Product: FluoBolt™ Periostin

Product: Haematex DOAC test

Product: Haematex Ellagic Acid

Product: HCC-REAAD™ ERBB3 ELISA Kit

Product: HemosIL Special Test Control L2

Product: ImmunoDiagnostics High-Sensitive Human C-Reactive Protein ELISA kit

Product: ImmunoDiagnostics Human FGF-19 ELISA Kit

Product: ImmunoDiagnostics Human FGF-21 ELISA kit

Product: ImmunoDiagnostics Human Galectin-3 ELISA kit

Product: ImmunoDiagnostics Human Plasminogen Activator Inhibitor Type-1 (PAI-1) ELISA kit

Product: ImmunoDiagnostics Human Thrombospondin-2 (TSP-2) ELISA Kit

Product: ImmunoDiagnostics Rapid High-Sensitive Human C-Reactive Protein ELISA kit

Product: Rossix FXIa Calibrator

Product: Rossix FXIa Control

Product: Rox Factor XIa

Product: Technochrom® FXIII Kit

Product: Technoclone Anti-tPA Monoclonal Antibody 3VPA

Product: Technoclone Factor XI Deficient Plasma, Native

Product: Technoclone Factor XII Deficient Plasma, Native

Product: Technoclone Factor XIII Deficient Plasma

Product: Technoclone Fitzgerald Trait Plasma

Product: Technoclone Siron LIS (aPTT liquid), 10x10ml

Product: Technoclone Siron LIS (aPTT liquid), 10x4ml

Product: Technoclone Siron LIS (aPTT liquid), 2x4ml

Product: Technoclone Siron LS (aPTT liquid), 10x10ml

Product: Technoclone Siron LS (aPTT liquid), 10x4ml

Product: Technoclone Siron LS (aPTT liquid), 2x4ml

Product: Technofluor® FXIII Activity

Product: Technoview® Edoxaban Calibrator Set

Product: Technoview® Edoxaban Control High

Product: Technoview® Edoxaban Control Low

Product: Technoview® Edoxaban Control Medium

Product: Technozym® Factor XIII Subunit A

Product: Technozym® Factor XIII Subunit B

Product: von Willebrand Factor Propeptide (vWF:PP) ELISA Test Kit

Page: A Review of the XXXVth International Symposium on Technical Innovations in Laboratory Hematology 2023 (ISLH 2023)

Page: A Trio of Biomarkers: A Novel Multivariate Model to Detect DILI & Liver Damage

Page: Activated partial thromboplastin time (aPTT)

Page: Activated Protein C (APC) and Factor V Leiden

Page: Activated Protein C Resistance (APCR), Factor V Leiden (FVL), and a Case Report of a Family with the presence of FVL over 5 generations.

Page: Alcohol-associated Liver Disease

Page: Alpha1-antitrypsin (α1-antitrypsin)

Page: Anticoagulation

Page: Antithrombin (ATIII)

Page: Assays for your Gene Therapy Research in Rare Diseases

Page: Atherosclerosis

Page: C-reactive protein (CRP)

Page: C1 Esterase Inhibitor (C1 INH)

Page: Cannabinoid effects on coagulation? Does organic weed mess with your blood flow?

Page: CHOOSING WISELY - Coagulation Testing Recommendations

Page: Clot Club

Page: Clot Club - Here The Clot Thickens

Page: Coagulation

Page: Company

Page: COMPREHENSIVE PRIMARY HEMOSTASIS ASSESSMENTS TO DIAGNOSE AND MONITOR VWD

Page: COVID-19 & Thrombosis Research

Page: COVID-19 - Frequently Asked Questions

Page: COVID-19 and Clotting Blog Post PART 1

Page: COVID-19 and Clotting Blog Post PART 2

Page: Dabigatran

Page: Detecting Hemoglobin Variants during Sickle Cell Disease Research: Which Method is Best?

Page: Direct Oral Anticoagulants (DOACs)

Page: Early Insights from RSA 2023

Page: Emerging Therapeutic Targets for Hereditary Angioedema

Page: Factor IX (FIX)

Page: Factor V (FV)

Page: Factor VIII (FVIII)

Page: Factor XI (FXI)

Page: Factor XII (FXII)

Page: Factor XIII

Page: Factor XIII (FXIII)

Page: Fibrinogen

Page: Fibrinolysis

Page: Fibronectin

Page: HDL/LDL

Page: Hemophilia

Page: Hemostasis

Page: Heparin

Page: Heparin-Induced Thrombocytopenia (HIT) - A sensible laboratory approach (hopefully)

Page: HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?

Page: HTRS 2019 Conference Summary

Page: Hypercoagulation During Sickle Cell Disease

Page: Immune-mediated Liver Injury caused by Checkpoint Inhibitors (ILICI)

Page: In vitro Liver Culture Systems to Investigate DILI

Page: Insights into an Imbalanced vWF antigen to ADAMTS-13 activity ratio in COVID-19

Page: International

Page: ISTH 2020

Page: ISTH 2021

Page: ISTH 2023 Blog Compilation

Page: IVIG

Page: Kininogen

Page: Laboratory Tests for von Willebrand Factor (VWF)

Page: Liver and Coagulation

Page: Lupus Anticoagulants/Antiphospholipid Antibodies/Antiphospholipid Antibody Syndrome – Part 2

Page: Matrix metalloproteinases (MMPs)

Page: Neutrophil Extracellular Traps

Page: Noggin

Page: Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH)

Page: On Sale Now

Page: Osteopontin

Page: Periostin

Page: Plasminogen (PLG)

Page: POTENTIAL FUTURE USES FOR RECOMBINANT ADAMTS13

Page: Prekallikrein/Kallikrein

Page: Proposed Mechanisms of Platelet Dynamics during COVID-19

Page: Protein C

Page: Protein S

Page: Protein Z

Page: Prothrombin

Page: Rivaroxaban (Xarelto®)

Page: Rossix

Page: Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?

Page: The Chromogenic Factor X Assay (CFX)

Page: The Debate of Early-Liver Transplantation for Alcohol-associated Liver Diseases

Page: The Latest Research on Direct Oral Anticoagulant (DOAC) Interferences in Testing

Page: THE NEW NOVEL ANTICOAGULANTS XI(a) and XII(a). THE CONTACT FACTOR INHIBITORS: Battling thromboembolism.

Page: Thrombin

Page: Thrombodynamics®

Page: Thrombophilia

Page: Thrombosis and Hemostasis in Liver Disease and Kidney Disease: A call for More Research

Page: Thrombotic Thrombocytopenic Purpura (TTP) Clinical Trials: Targeting the needs left by current treatment options

Page: THSNA 2020 Virtual Meeting

Page: THSNA 2022 Recap

Page: Tissue Plasminogen Activator (tPA)

Page: Tools for Sickle Cell Disease Research

Page: UPDATE ON THE DIRECT ORAL ANTICOAGULANTS (DOACs): WHERE ARE WE IN THE LABORATORY ALMOST TEN YEARS LATER?

Page: von Willebrand Disease

News: 12th International Society for Study of Xenobiotics (ISSX 2019)

News: 25th International Fibrinogen & 3rd International Factor XIII Workshop

News: 27th Congress of the International Society of Thrombosis and Haemostasis and 65th Annual Scientific and Standardization Committee (SSC) (ISTH 2019)

News: 2nd Annual Hemophilia Drug Development (HDD) Summit

News: 2nd Annual Nonalcoholic Steatohepatitis (NASH) Summit

News: 70th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo

News: Assays Available from Diapharma

News: Assays for IVIG Testing

News: Assays for your Gene Therapy Research in Rare Diseases

News: Celebrate with DiaPharma at THSNA in Chicago

News: Chromogenic Factor VIII and FIX Assays For Hemophilia Studies

News: Clot Club #28

News: Clot Club #5

News: Clot Club: Hypercoagulation During Sickle Cell Disease

News: Complement Biomarkers for Alcoholic Liver Disease Research

News: Connect with DiaPharma at AACC 2023

News: Connect with DiaPharma at ASH 2022 in New Orleans